AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Centene Stock Plunges 26.6% After Guidance Withdrawal
Generated by AI AgentAinvest Pre-Market Radar
Wednesday, Jul 2, 2025 5:50 am ET1min read
On July 2, 2025, Centene's stock plummeted by 26.6% in pre-market trading, marking a significant downturn for the health insurer.
Centene Corp. shares tumbled after the health insurer pulled its 2025 guidance, citing insurance market trends that veered from its assumptions and threaten its financial outlook.
UBS revised its earnings per share estimates for
, projecting a significant decline for 2025, which contributed to the stock's downturn.Centene decided to withdraw its earlier 2025 guidance for profit and adjusted profit, further impacting investor confidence and leading to a sharp decline in its stock price.
BofA Securities analyst Kevin Fischbeck lowered the price target on Centene to $52.00, reflecting the company's uncertain financial outlook and the withdrawal of its 2025 guidance.
Centene's shares are tumbling in Tuesday's after-hours session after the health care company withdrew its guidance for 2025, causing a significant drop in its stock price.
Ainvest Pre-Market Radar
Get the scoop on pre-market movers and shakers in the US stock market.
Latest Articles
Serve Robotics Surges 5.16% as Trump Admin Boosts Robotics Push, Eyes 10X Revenue by 2026
Dec.12 2025
New Pacific Metals (NPM) Soars 7.98% as Base Metals Market Anticipates Supply/Demand Shifts
Dec.12 2025
Gevo Inc. (GEVO) Surges 6.22% on $26M BioRecro Partnership to Expand Carbon Management Capabilities
Dec.12 2025
Sable Offshore Soars 5.82% as Private Placement and Policy Tailwinds Drive Pre-Market Rally
Dec.12 2025
Mastercard Inc. Surges 4.55% as Fintech Optimism and AI Expansion Drive Pre-Market Rally
Dec.12 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet